Testing of natural products in clinical trials targeting the SARS-CoV-2 (Covid-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction
Gary Williamson, Asimina Kerimi
Topics & Concepts
In silicoPharmacologyQuercetinAngiotensin-converting enzyme 2EnzymeSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Angiotensin-converting enzymeBiotransformationVirologyChemistryBiologyBiochemistryMedicineInternal medicineEndocrinologyAntioxidantInfectious disease (medical specialty)Blood pressureDiseaseGeneComputational Drug Discovery MethodsToxin Mechanisms and ImmunotoxinsSARS-CoV-2 and COVID-19 Research